Every SEC Form 3/4/5 on record for this filer (CIK 1213895) — 6 issuers, 26 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| ALEC | Alector, Inc. | Director | 2024-03-21 → 2026-06-17 | 4 | — |
| RPRX | Royalty Pharma plc | Director | 2020-06-15 → 2025-05-14 | 8 | — |
| CYCN | Cyclerion Therapeutics, Inc. | Director · lapsed | 2021-05-19 → 2023-12-04 | 4 | — |
| CBIO | CRESCENT BIOPHARMA, INC. | Director · lapsed | 2015-10-26 → 2021-10-05 | 20 | — |
| BIOD | Biodel Inc | CEO · Director · lapsed | 2015-10-02 → 2015-10-02 | 1 | — |
| TRGT | TARGACEPT INC | Director · lapsed | 2015-08-18 → 2015-08-18 | 1 | — |
No open-market buy or sale on record — only grants, exercises, withholding or gifts. Switch to “All forms” to see them.
4 of 6 issuers are covered and open a security page; the rest are on file here only.